Monoamine oxidase inhibitory and CNS activities of some quinazolinones.
16 new compounds have been synthesised in the series of 3-aryl-2-(1'-aryl-piperazin-4'-yl-carboxamidomethyl)-mercapto-quinazolinones. The compounds showed interesting results in anticonvulsant, hypnotic and monoamine oxidase (MAO) inhibitory screenings and are non-toxic. SAR were evaluated.